ADENOCARCINOMA
Clinical trials for ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to tame tough pancreatic cancer
Disease control OngoingThis early study tests whether combining two drugs, pembrolizumab and lenvatinib, can help control advanced pancreatic cancer that has not responded to prior treatment. About 15 adults with metastatic pancreatic adenocarcinoma will receive the combination. The goal is to see if t…
Matched conditions: ADENOCARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
Radioactive antibody takes aim at Hard-to-Treat prostate cancer
Disease control OngoingThis early-stage study tests a new drug called JNJ-69086420 for men with advanced prostate cancer that has spread and is no longer responding to standard hormone therapy. The drug is an antibody carrying a radioactive payload that targets a protein found on prostate cancer cells.…
Matched conditions: ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
Mini GPS in a needle could make cancer biopsies more precise
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a special needle with a tiny tracking device inside, like a mini GPS, to help doctors find hard-to-see tumors during biopsies or ablation procedures. About 3,900 adults with certain cancers or growths will take part. The goal is to see if this tool can place the …
Matched conditions: ADENOCARCINOMA
Phase: NA • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
15-Year checkup: what happens after experimental cancer therapy?
Knowledge-focused ENROLLING_BY_INVITATIONThis study does not provide new treatment. Instead, it follows up to 1,150 people who previously received experimental cell or gene therapies for cancers like melanoma and neuroendocrine tumors. Participants will have yearly physical exams and blood tests for up to 15 years to mo…
Matched conditions: ADENOCARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC